Pelthos Therapeutics, Inc. (PTHS)
24.73
-0.27
(-1.08%)
USD |
NYAM |
Aug 28, 16:00
24.46
-0.27
(-1.09%)
After-Hours: 20:00
Pelthos Therapeutics Total Assets (Quarterly) : 137.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 137.36M |
| March 31, 2026 | 145.38M |
| December 31, 2025 | 130.40M |
| September 30, 2025 | 126.43M |
| June 30, 2025 | 0.9112M |
| March 31, 2025 | 0.9112M |
| September 30, 2024 | 2.140M |
| Date | Value |
|---|---|
| June 30, 2024 | 2.604M |
| March 31, 2024 | 4.032M |
| December 31, 2023 | 0.0964M |
| September 30, 2023 | 0.0228M |
| June 30, 2023 | 0.0819M |
| March 31, 2023 | 0.0486M |
| December 31, 2022 | 0.0551M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Travere Therapeutics, Inc. | 799.36M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 138.86M |
| Shareholders Equity (Quarterly) | -1.501M |
| Debt to Equity Ratio | -48.71 |
| Current Ratio | 1.982 |
| Net Debt Paydown Yield | -13.44% |